ODN 2336-Type A (human)
2779.8 EUR
In Stock
quantity
Produktdetaljer
Katalognummer: 708 - VAdv-Ly0065-1mg
Produktkategori: Företag och industri > Vetenskap och laboratorium
Gentaur
Storlek: 1 mg
VAdv-Ly0065-1mg
ODN 2336-Type A (human)
ODN 2336-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.
2779.8 €
VAdv-Ly0065-5mg
ODN 2336-Type A (human)
ODN 2336-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.
8223 €
HY-150742
ODN 2336
ODN 2336 is a A-Class CpG ODN (oligodeoxynucleotides), is a potent TLR9 agonist. ODN 2336 induces the production of IFN-α. ODN 2336 up-regulates the expression of IP-10 mRNA and IL-18 mRNA. ODN 2336 can be used as adjuvant of vaccines[1][2][3].
1623.46 €
HY-146245
ODN 1826
ODN 1826 (CpG 1826), a class B CpG ODN (oligodeoxynucleotide), is a TLR9 agonist. ODN 1826 promotes Apoptosis. ODN 1826 is an excellent immune stimulator with antitumor activity. ODN 1826 has protective effects on the heart. ODN 1826 sequence: 5’-tccatgacgttcctgacgtt-3’[1][2][3][4].
1623.46 €
HY-150215
ODN 105870
ODN 105870, a G-modified inhibitory oligonucleotide (INH-ODN), is a selective TLR7 inhibitor. ODN 105870 can be uesd for inflammatory immune responses research[1].
Ask for quotation
HY-150216
ODN 105871
ODN 105871, a G-modified inhibitory oligonucleotide (INH-ODN), is a selective TLR7 inhibitor. ODN 105871 can be uesd for inflammatory immune responses research[1].
Ask for quotation
Håll dig uppdaterad! Visa tidigare publikationer
By: Author , 2 Comment
Anaplasmos hos hundar och katter – allt du behöver veta
23 August 2025
By: Author , 2 Comment
Solbränna – hur leker man säkert i solen?
16 August 2025
By: Author , 2 Comment
Biologiska läkemedel – Modernitet inom farmaci
1 August 2025
By: Author , 2 Comment
Icke-steroida antiinflammatoriska läkemedel – viktig information om populära läkemedel
22 July 2025